Viewing Study NCT01656304


Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2025-12-25 @ 7:09 PM
Study NCT ID: NCT01656304
Status: COMPLETED
Last Update Posted: 2018-07-31
First Post: 2012-07-30
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-05
Start Date Type: None
Primary Completion Date: 2012-01
Primary Completion Date Type: ACTUAL
Completion Date: 2012-06
Completion Date Type: ACTUAL
First Submit Date: 2012-07-30
First Submit QC Date: None
Study First Post Date: 2012-08-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-06-06
Results First Submit QC Date: None
Results First Post Date: 2014-07-08
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-07-01
Last Update Post Date: 2018-07-31
Last Update Post Date Type: ACTUAL